Abeona Therapeutics Inc. (ABEO)

NASDAQ: ABEO · Real-Time Price · USD

5.57

-0.02 (-0.36%)

At close: Sep 18, 2026, 4:00 PM EDT

5.68

+0.11 (1.97%)

After-hours: Sep 18, 2026, 7:58 PM EDT

Abeona Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 18, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	319	286	242	124	53	49
Market Cap Growth	10.14%	17.95%	95.09%	134.61%	7.07%	-68.06%
Enterprise Value	192	103	156	76	43	-11
Last Close Price	5.57	5.27	5.57	5.01	3.08	8.43

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 18, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	-	4.01	-	-	-	-
Forward PE	-	231.80	-	-	-	-
PS Ratio	12.48	49.07	-	35.46	37.41	16.47
PB Ratio	2.49	1.79	5.50	8.37	1.98	1.17
P/TBV Ratio	2.49	1.79	5.50	8.37	1.98	1.21

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 18, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
EV/Sales Ratio	7.51	17.63	-	21.73	30.43	-

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 18, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Debt / Equity Ratio	0.16	0.16	0.52	0.36	0.28	0.22
Net Debt / Equity Ratio	-0.99	-1.04	-1.70	-3.16	-1.66	-0.84
Net Debt / EBITDA Ratio	1.57	1.92	1.20	1.02	1.06	0.66
Net Debt / FCF Ratio	1.56	1.97	1.28	1.25	1.02	0.51
Asset Turnover	0.12	0.04	-	0.06	0.02	0.03
Quick Ratio	6.32	6.70	5.99	4.07	6.73	2.89
Current Ratio	6.64	6.93	6.08	4.15	6.83	3.39
Return on Equity (ROE)	-43.13%	70.05%	-216.57%	-260.60%	-114.85%	-117.22%
Return on Assets (ROA)	-24.55%	-34.04%	-46.41%	-46.99%	-39.34%	-31.07%
Return on Invested Capital (ROIC)	-17696.30%	-	-	-	-	-499.52%
Return on Capital Employed (ROCE)	-54.00%	-47.10%	-69.50%	-95.30%	-80.20%	-91.10%

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 18, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Earnings Yield	-19.74%	24.93%	-26.32%	-43.66%	-75.04%	-171.90%
FCF Yield	-25.60%	-29.52%	-24.14%	-30.09%	-82.44%	-141.30%
Buyback Yield / Dilution	1.73%	-61.12%	-91.99%	-171.96%	-99.65%	-6.24%

SEC Filings: 10-K · 10-Q